For Investors

Press Releases

ReWalk Robotics Finalizes U.S. Distribution Agreements for Two Additional Neuro Rehabilitation Product Lines

06/04/20

-- Additional Lines Expand Company’s Portfolio and Include Telehealth Capable Stroke Rehabilitation Devices as well as Clinic and Home Use Devices for Persons with Spinal Cord Injury -- MARLBOROUGH, Mass. , June 04, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics , Ltd. (Nasdaq: RWLK) ("ReWalk," “we” or

Centers for Medicare & Medicaid Services Issues Positive Preliminary Coding Decision for ReWalk Exoskeleton

06/02/20

New HCPCS Level II Code for Exoskeletons Would Be a Significant Step Towards Access to Exoskeletons for Individuals with Spinal Cord Injuries MARLBOROUGH, Mass. , June 2, 2020 /PRNewswire/ --  ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical

ReWalk Robotics Reports First Quarter 2020 Financial Results

05/28/20

— Q1 2020 Total Revenue of $0.8 million at a reduced level due to COVID-19 pandemic — — German coverage broadly expanded with social accident and statutory insurance —             —   Expanding our portfolio by offering two new product lines— MARLBOROUGH, Mass.

ReWalk Robotics to Report First Quarter 2020 Financial Results on May 28, 2020

05/26/20

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , May 26, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2020 financial results on Thursday, May 28, 2020 , before the U.S.

ReWalk Robotics Increases Focus on Telehealth Opportunities

05/19/20

Continuing collaboration with engineers at Harvard addresses telehealth needs for rehabilitation and physical therapy in wake of COVID-19 MARLBOROUGH, Mass., May 19, 2020 /PRNewswire/ -- Four years after entering into a collaboration with researchers at Harvard University to develop wearable

ReWalk Robotics Increases Focus on Telehealth Opportunities

05/19/20

Continuing collaboration with engineers at Harvard addresses telehealth needs for rehabilitation and physical therapy in wake of COVID-19 MARLBOROUGH, Mass. , May 19, 2020 /PRNewswire/ -- Four years after entering into a collaboration with researchers at Harvard University to develop wearable

ReWalk Announces Binding Offer to Deutsche Gesetzliche Unfallversicherung (DGUV) - German Social Accident Insurance

05/12/20

83 million Germans, covered for work and commuting-related accidents, have the opportunity to access ReWalk products if the requirements and personal suitability are met MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel and BERLIN , May 12, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd.

ReWalk Enters Agreements with Leading German Insurers TK and DAK-Gesundheit to Provide Coverage of Robotic Exoskeletons for Individuals with Spinal Cord Injuries

04/23/20

Two National Insurers Representing More Than 16 Million Germans Will Supply Eligible Paralyzed Beneficiaries with ReWalk 6.0 Exoskeleton Devices MARLBOROUGH, Mass and BERLIN , April 23, 2020 /PRNewswire/ --  ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of

ReWalk Letter to Shareholders on COVID-19 and the Potential Impact on Operations

03/24/20

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , March 24, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) a global leader in Exoskeleton technology for community use and rehabilitation centers, today issued the following letter to shareholders: To All Shareholders: The

ReWalk Announces Progress with German Statutory Health Insurer to Provide Coverage of Robotic Exoskeletons for Individuals With Spinal Cord Injuries

03/18/20

2018 Addition of ReWalk 6.0 to German National Device Directory Is Expected to Pave the Way for German Insurers to Develop Policies to Supply Paralyzed Beneficiaries with Exoskeletons MARLBOROUGH, Mass. and BERLIN , March 18, 2020 /PRNewswire/ --  ReWalk Robotics, Ltd.

ReWalk Robotics Reports Fourth Quarter and Year End 2019 Financial Results

02/20/20

— 2019 Total Revenue of $4.9 million and $1.2 million During the Fourth Quarter of 2019 — — Completed and Pending German Insurance Contracts Establish the Implementation Procedures for Coverage of the German Spinal Cord Population —             — CMS HCPCS Code Application Submitted; Hearing

ReWalk Robotics to Report Fourth Quarter and Year-End 2019 Financial Results on February 20, 2020

02/17/20

MARLBOROUGH, Mass. , BERLIN and YOKNEAM ILIT, Israel , Feb. 17, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter and year-end 2019 financial results on Thursday, February 20, 2020 , before the